Haloperidol and risperidone in the treatment of delirium and its subtypes

European Journal of Psychiatry

Volumn 25, Issue 2, 2011, Pages 59-67

  Boettger, Soenke ^a   Breitbart, William ^b   Passik, Steven ^b  

^a BELLEVUE HOSPITAL CENTER   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Antipsychotics; Delirium; Haloperidol; Risperidone; Treatment

Indexed keywords

CORTICOSTEROID; HALOPERIDOL; OPIATE; RISPERIDONE;

ADULT; AGED; ARTICLE; BRAIN CANCER; CANCER STAGING; CENTRAL NERVOUS SYSTEM DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; DEHYDRATION; DELIRIUM; DIGESTIVE SYSTEM CANCER; DRUG EFFICACY; DRUG SAFETY; FEMALE; GYNECOLOGIC CANCER; HEAD AND NECK CANCER; HUMAN; HYPOXIA; INFECTION; KARNOFSKY PERFORMANCE STATUS; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MEMORIAL DELIRIUM ASSESSMENT SCALE; METABOLIC DISORDER; PSYCHOPHARMACOTHERAPY; RATING SCALE; SARCOMA; SKIN CANCER; TREATMENT RESPONSE; UROGENITAL TRACT CANCER;

EID: 80052591753     PISSN: 02136163     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Trzepacz P.T., Breitbart W., Franklin J., Levenson J., Martini R., Wang P. Practice Guideline for the treatment of patients with Delirium. American Psychiatric Association. Am J Psychiatry 1999; 156(5 Suppl): 1-20. (Pubitemid 29220060)
2. Bucht G., Gustafson Y., Sandberg O. Epidemiology of Delirium. Dement Geriatr Cogn Disord 1999; 10(5): 315-318. (Pubitemid 29403586)
3. Lipowski Z.J. Delirium in the elderly patient. N Engl J Med 1989; 320(9): 578-582. (Pubitemid 19070543)
4. Bond S.M., Neelon V.J., Belyea M.J. Delirium in hospitalized older patients with cancer. Oncol Nurs Forum 2006; 33(6): 1075-1083.
5. Breitbart W., Strout D. Delirium in the terminally ill. Clin Geriatr Med 2000; 16(2): 357-372. (Pubitemid 30331642)
6. Massie M.J., Holland J., Glass E. Delirium in terminally ill cancer patients. Am J Psychiatry 1983; 140(8): 1048-1050. (Pubitemid 13028678)
7. Inouye S.K. Delirium in hospitalized older patients. Clin Geriatr Med 1998; 14(4): 745-764. (Pubitemid 28553403)
8. Lonergan E., Britton A.M., Luxenberg J., Wyller T. Antipsychotics for Delirium. Cochrane Database Syst Rev 2007; (2): CD005594.
9. Boettger S., Breitbart W. Atypical antipsychotics in the management of delirium: A review of the empirical literature. Palliat Support Care 2005; 3(3): 227-237.
10. Liu C.Y., Juang Y.Y., Liang H.Y., Lin N.C., Yeh E.K. Efficacy of risperidone in treating the hyperactive symptoms of delirium. Int Clin Psychopharmacol 2004; 19(3): 165-168.
11. Han C.S., Kim Y.K. A double-blind trial of risperidone and haloperidol for the treatment of delirium. Psychosomatics 2004; 45(4): 297-301.
12. Kim J.Y., Jung I.K., Han C., Cho S.H., Kim L., Kim S.H., et al. Antipsychotics and dopamine transporter gene polymorphisms in delirium patients. Psychiatry Clin Neurosci 2005; 59(2): 183-188. (Pubitemid 40524954)
13. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000.
14. Breitbart W., Rosenfeld B., Roth A., Smith M.J., Cohen K., Passik S. The Memorial Delirium Assessment Scale. J Pain Symptom Manage 1997; 13(3): 128-137. (Pubitemid 27172870)
15. Lawlor P.G., Nekolaichuk C., Gagnon B., Mancini I.L., Pereira J.L., Bruera E.D. Clinical utility, factor analysis, and further validation of the Memorial Delirium Assessment Scale in patients with advanced cancer: Assessing delirium in advanced cancer. Cancer 2000; 88(12): 2859-2867. (Pubitemid 30417951)
16. Meagher D.J., O'Hanlon D., O'Mahony E., Casey P.R., Trzepacz P.T. Relationship between symptoms and motoric subtype of delirium. J Neuropsychiatry Clin Neurosci 2000; 12(1): 51-56. (Pubitemid 30093689)
17. Meagher D., Moran M., Raju B., Leonard M., Donnelly S., Saunders J., et al. A new data-based motor subtype schema for delirium. J Neuropsychiatry Clin Neurosci 2008; 20(2): 185-193.
18. Meagher D.J., Moran M., Raju B., Gibbons D., Donnelly S., Saunders J., et al. Motor symptoms in 100 patients with delirium versus control subjects: Comparison of subtyping methods. Psychosomatics 2008; 49(4): 300-308. (Pubitemid 351905203)
19. Karnofsky D.A., Burchenal J.H. The clinical evaluation of chemotherapeutic agents in cancer. In: Mc Leod CM, ed. The evaluation of chemotherapeutic agents. New York: Columbia University Press; 1949. p. 191-205.
20. Lingjaerde O., Ahlfors U.G., Bech P., Dencker S.J., Eigen K. The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr Scand Suppl 1987; 334: 1-100. (Pubitemid 17115352)
21. Horikawa N., Yamazaki T., Miyamoto K., Kurosawa A., Oiso H., Matsumoto F., et al. Treatment for delirium with risperidone: Results of a prospective open trial with 10 patients. Gen Hosp Psychiatry 2003; 25(4): 289-292. (Pubitemid 36802275)
22. Mittal D., Jimerson N.A., Neely E.P., Johnson W.D., Kennedy R.E., Torres R.A., et al. Risperidone in the treatment of delirium: Results from a prospective open-label trial. J Clin Psychiatry 2004; 65(5): 662-667.
23. Parellada E., Baeza I., De Pablo J., Martinez G. Risperidone in the treatment of patients with delirium. J Clin Psychiatry 2004; 65(3): 348-353.
24. Uchida H., Kapur S., Mulsant B.H., Graff-Guerrero A., Pollock B.G., Mam D.C. Sensitivity of older patients to antipsychotic motor side effects: A PET Study examining potential mechanisms. Am J Geriatr Psychiatry 2009; 17(3): 255-263.
25. Breitbart W., Marotta R., Platt M.M., Weisman H., Derevenco M., Grau C., et al. A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients. Am J Psychiatry 1996; 153(2): 231-237. (Pubitemid 26038965)
26. Platt M.M., Breitbart W., Smith M., Marotta R., Weisman H., Jacobsen P.B. Efficacy of neuroleptics for hypoactive delirium. J Neuropsychiatry Clin Neurosci 1994; 6(1): 66-67.
27. Schwartz T.L., Masand P.S. Treatment of delirium with quetiapine. Prim Care Companion J Clin Psychiatry 2000; 2(1): 10-12.
28. Skrobik Y.K., Bergeron N., Dumont M., Gottfried S.B. Olanzapine vs haloperidol: Treating delirium in a critical care setting. Intensive Care Med 2004; 30(3): 444-449. (Pubitemid 38375619)
29. Sipahimalani A., Masand P.S. Olanzapine in the treatment of delirium. Psychosomatics 1998; 39(5): 422-430. (Pubitemid 28439942)